| Literature DB >> 27694529 |
Kerstin Lohr1, Fiona Pachl2, Amin Moghaddas Gholami2, Kerstin E Geillinger3, Hannelore Daniel3, Bernhard Kuster2, Martin Klingenspor4.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is a major health burden in the aging society with an urging medical need for a better understanding of the underlying mechanisms. Mitochondrial fatty acid oxidation and mitochondrial-derived reactive oxygen species (ROS) are considered critical in the development of hepatic steatosis, the hallmark of NAFLD. Our study addressed in C57BL/6J mice the effect of high fat diet feeding and age on liver mitochondria at an early stage of NAFLD development. We therefore analyzed functional characteristics of hepatic mitochondria and associated alterations in the mitochondrial proteome in response to high fat feeding in adolescent, young adult, and middle-aged mice. Susceptibility to diet-induced obesity increased with age. Young adult and middle-aged mice developed fatty liver, but not adolescent mice. Fat accumulation was negatively correlated with an age-related reduction in mitochondrial mass and aggravated by a reduced capacity of fatty acid oxidation in high fat-fed mice. Irrespective of age, high fat diet increased ROS production in hepatic mitochondria associated with a balanced nuclear factor erythroid-derived 2 like 2 (NFE2L2) dependent antioxidative response, most likely triggered by reduced tethering of NFE2L2 to mitochondrial phosphoglycerate mutase 5. Age indirectly influenced mitochondrial function by reducing mitochondrial mass, thus exacerbating diet-induced fat accumulation. Therefore, consideration of age in metabolic studies must be emphasized.Entities:
Keywords: Age; diet‐induced obesity; fatty acid oxidation; mitochondria; nonalcoholic fatty liver disease; proteomics
Mesh:
Substances:
Year: 2016 PMID: 27694529 PMCID: PMC5064140 DOI: 10.14814/phy2.12988
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Composition of experimental diets
| Ingredient | Control diet | High fat diet |
|---|---|---|
| Protein (kJ%) | 23.0 | 18.0 |
| Carbohydrates (kJ%) | 65.0 | 34.0 |
| Fat (kJ%) | 12.0 | 48.0 |
| Energy content (kJ/g) | 15.5 | 22.7 |
| Casein (wt%) | 24.0 | 24.0 |
| Corn starch (wt%) | 45.9 | 26.7 |
| Sucrose (wt%) | 5.0 | 5.0 |
| Maltodextrin (wt%) | 5.6 | 5.6 |
| Soy oil (wt%) | 5.0 | 5.0 |
| Palm oil (wt%) | – | 20.0 |
| Cellulose (wt%) | 5.0 | 5.0 |
| Mineral mixture (wt%) | 6.0 | 6.0 |
| Vitamin mixture (wt%) | 1.2 | 1.2 |
Body composition and glucose metabolism of three age groups of mice after 9 weeks of high fat diet feeding. At the onset of the dietary intervention mice were either at the age of 8 weeks (adolescent), 16 weeks (young adult), or 52 weeks (middle‐aged)
| Adolescent | Young adult | Middle‐aged | Two‐way ANOVA | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Control | High fat | Control | High fat | Control | High fat |
|
|
| |
| Body mass initial | 21.4 ± 0.9 | 21.2 ± 0.9 | 26.6 ± 0.8 | 26.1 ± 0.9 | 30.2 ± 0.7 | 30.2 ± 1.1 | <0.001 | n.s. | n.s. |
| Body mass final | 24.7 ± 0.7 | 29.5 ± 1.0 | 27.8 ± 0.7 | 36.0 ± 2.4 | 30.7 ± 0.9 | 43.7 ± 2.0 | <0.001 | <0.001 | <0.001 |
| Body mass gain | 3.2 ± 0.7 | 8.3 ± 1.1 | 1.2 ± 0.7 | 9.9 ± 2.3 | 0.4 ± 0.6 | 13.5 ± 2.4 | n.s. | <0.001 | <0.001 |
| Fat mass initial | 1.7 ± 0.2 | 1.8 ± 0.2 | 2.9 ± 0.5 | 2.7 ± 0.1 | 3.1 ± 0 5 | 3.4 ± 0.4 | <0.001 | n.s. | n.s. |
| Fat mass final | 2.1 ± 0.3 | 6.6 ± 0.8 | 3.1 ± 0.4 | 11.8 ± 1.7 | 3.5 ± 0.6 | 17.3 ± 1.2 | <0.001 | <0.001 | <0.001 |
| Fat mass gain | 0.4 ± 0.2 | 4.9 ± 0.8 | 0.2 ± 0.3 | 9.1 ± 1.8 | 0.4 ± 0.8 | 13.9 ± 1.2 | <0.001 | <0.001 | <0.001 |
| Lean mass initial | 16.1 ± 0.9 | 15.7 ± 0.8 | 19.6 ± 0.4 | 19.4 ± 0.6 | 22.7 ± 0.8 | 22.3 ± 0.7 | <0.001 | n.s. | n.s. |
| Lean mass final | 18.3 ± 0.8 | 19.5 ± 0.6 | 20.2 ± 0.6 | 19.8 ± 0.6 | 21.7 ± 0.5 | 21.2 ± 0.7 | <0.001 | n.s. | 0.003 |
| Lean mass gain | 2.2 ± 0.3 | 3.8 ± 0.6 | 0.6 ± 0.6 | 0.4 ± 0.3 | −1.0 ± 1.1 | −1.1 ± 1.4 | <0.001 | n.s. | 0.02 |
| Adjusted fat mass | 2.7 ± 0.4 | 11.6 ± 1.0 | 3.0 ± 0.3 | 12.1 ± 0.5 | 2.9 ± 2.9 | 12.0 ± 1.5 | n.s. | <0.001 | n.s. |
| Adjusted lean mass | 20 ± 0.5 | 20.4 ± 0.5 | 20.2 ± 0.4 | 19.8 ± 0.5 | 20.0 ± 0.7 | 20.3 ± 0.7 | n.s. | n.s. | n.s. |
| Fasting Glc Final | 7.7 ± 1.7 | 10.4 ± 0.9 | 9.4 ± 0.5 | 10.1 ± 1.4 | 7.6 ± 0.4 | 9.3 ± 1.1 | 0.03 | <0.001 | n.s. |
| Fasting Insulin | 0.6 ± 0.3 | 1.3 ± 0.6 | 0.6 ± 0.3 | 1.5 ± 0.5 | 1.0 ± 0.4 | 4.2 ± 1.1 | <0.001 | <0.001 | <0.001 |
| Total AUC | 177 ± 39 | 275 ± 32 | 229 ± 33 | 321 ± 63 | 227 ± 35 | 317 ± 23 | 0.007 | <0.001 | n.s. |
| Liver mass | 1.3 ± 0.1 | 1.2 ± 0.2 | 1.2 ± 0.1 | 1.5 ± 0.3 | 1.6 ± 0.1 | 1.7 ± 0.2 | <0.001 | n.s. | n.s. |
| Adjusted liver mass | 1.5 ± 0.1 | 1.2 ± 0.2 | 1.3 ± 0.1 | 1.4 ± 0.3 | 1.6 ± 0.1 | 1.4 ± 0.2 | n.s. | n.s. | n.s. |
n = 6 per diet and age group. Data are represented as means ± SD. Two‐Way ANOVA statistics for P(Age) – age effect, P(Diet) – diet effect, and P(AgeDiet) – interaction. n.s., not significant (P ≥ 0.05).
Results of post hoc testing are indicated by 1Significantly different to Adolescent within feeding group; 2Significantly different to Young Adult within feeding group; 3Significantly different to age‐matched control group.
4Adjustment for final body mass as covariate by ANCOVA.
5AUC – area‐under‐the‐curve of ipGTT in (min × g × L−1). Body mass, fat mass and lean mass, initial and final, body mass gain, fat mass gain, lean mass gain, adjusted fat mass, adjusted lean mass, liver mass, and adjusted liver mass – (g); fasting glucose – (mmol/L); fasting insulin – (ng × mL−1).
Figure 1(A) Hepatic triglyceride (TG) content and (B) mitochondrial (mt) mass in adolescent (A), young adult (YA), or middle‐aged (MA) mice after 9 weeks of either control diet or high fat diet feeding. n = 5–6 per age and diet group, Two‐Way ANOVA effects are indicated by asterisks: **P < 0.01; ***P < 0.001. Results of post hoc testing are indicated by #Significantly different to age‐matched control group; $Significantly different to A within feeding group; ‡Significantly different to YA within feeding group. Data are represented as means ± SD.
Oxygen consumption in isolated liver mitochondria of adolescent, young adult, and middle‐aged mice
| Oxygen consumption | Adolescent | Young adult | Middle‐aged | Two‐way ANOVA | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Control | High fat | Control | High fat | Control | High fat |
|
|
| ||
| Succ | −ADP | 13 ± 6 | 15 ± 7 | 27 ± 8 | 21 ± 5 | 50 ± 16 | 58 ± 19 | <0.001 | n.s. | n.s. |
| +ADP | 47 ± 19 | 42 ± 15 | 76 ± 28 | 57 ± 10 | 127 ± 23 | 155 ± 46 | <0.001 | n.s. | n.s. | |
| RCR | 3.8 ± 0.3 | 3.0 ± 0.7 | 2.7 ± 0.5 | 2.7 ± 0.3 | 2.7 ± 0.6 | 2.7 ± 0.2 | 0.002 | n.s. | n.s. | |
| PC/Mal | −ADP | 12 ± 3 | 10 ± 2 | 16 ± 4 | 14 ± 4 | 22 ± 5 | 20 ± 4 | <0.001 | n.s. | n.s. |
| +ADP | 69 ± 15 | 47 ± 7 | 83 ± 11 | 82 ± 25 | 95 ± 23 | 75 ± 9 | 0.002 | 0.02 | n.s. | |
| RCR | 6.0 ± 1.0 | 4.9 ± 1.0 | 5.4 ± 1.5 | 5.8 ± 1.4 | 4.3 ± 0.5 | 3.8 ± 0.7 | 0.002 | n.s. | n.s. | |
RCR, respiratory control ratio.
Results of post hoc testing are indicated by 1Significantly different to Adolescent within feeding group;
2ignificantly different to Young Adult within feeding group;
3Significantly different to age‐matched control group.
4nmol O2 × mg−1 × min−1, Succ, succinate/rotenone, PC/Mal, palmitoylcarnitine/Malate.
Data are represented as means ± SD; n = 5–6 per group; Two‐Way ANOVA statistics for P(Age) ‐ age effect, P(Diet) ‐ diet effect, and P(AgeDiet) ‐ interaction.
Figure 2(A) Mitochondrial ROS production rates, monitored as H2O2 released by liver mitochondria, isolated from adolescent (A), young adult (YA), and middle‐aged (MA) mice fed either a high fat or control diet for 9 weeks. Mitochondrial respiration was initiated with succinate/rotenone in absence of ADP. (B) Scatter plot analysis of mitochondrial ROS production rates plotted versus membrane potential or (D) oxygen consumption rate during leak respiration. Based on the regression equations shown in (B) and D), the respective residual ROS production rates were calculated in (C) and (E). n = 4–6 per age and diet group. Two‐Way ANOVA statistics are indicated with **P < 0.01; ***P < 0.001; results of post hoc testing are indicated by #Significantly different to age‐matched control group; $Significantly different to A within feeding group. Data are represented as means ± SD.
Figure 3(A) Number of all different identified proteins and attributed subcellular localization, (B) Total abundance of proteins identified and attributed to subcellular localization, (C) Hierarchical clustering of proteins significantly regulated by high fat (HF) diet, and (D) age‐related clustering of proteins regulated by high fat diet. A, adolescent; YA, young adult; MA, middle‐aged
Overview and gene ontologies in respect to “Biological Function” of 86 mitochondrial proteins identified to be regulated by diet
| Mitochondrial proteins | ||
|---|---|---|
| GO biological function | Protein name | |
| DOWN | UP | |
| Heme biosynthesis | FECH, PPOX | |
| Programmed cell death | PGAM5 | |
| Nucleotide biosynthesis | DTYMK | |
| Peptidases | CTSA, CTSB | |
| Purine metabolism | UOX, 1190003J15Rik | |
| Sphingolipid metabolic process | PSAP | |
| Aminotransferase | AGXT | OAT, AGXT‐2, GOT2 |
| Amino acid catabolic pathway | AASS, GCAT | BCKDH, BCKDHB, BCKDHA, MCCC1, DMGDH, GCDH |
| Fatty acid beta‐oxidation | HADHA, CROT, EHHADH | ACAD10, ACADS, ACAA2, CYB5A, PCCA |
| Hydroxyacid‐oxoacid transhydrogenase | ADHFE1 | ADHFE1 |
| Inner mitochondrial membrane organization | MINOS1 | OPA1, LETM1 |
| Mitochondrial translation | MRPL24, MRPS5 | MRPS7 |
| Protein import | SAMM50 | PMPCA |
| Respiratory chain | CYTCS, NDUFS6, NDUFAF4, ATP5D | NDUFAF1 |
| Response to oxidative stress | CAT, SOD1 | MSRA, DNAJC11, MGST1 |
| Sulfur metabolism | ETHE1 | SUOX, SQRDL |
| Urea cycle | CPS1 | OTC |
| Acyl‐CoA ligase activity | ACSM3, ACSS3, ACSF2, SLC27A2 | |
| Calcium homeostasis | RMDN3 (Ptpip51) | |
| Cellular aldehyde metabolic process | ALDH3A2 | |
| Glutamate/glutamine metabolism | GLUL, GLUD1 | |
| Ketone body production | ACAT1 | |
| Oxidoreductase ‐ heme binding | CYP22D2, AKR7A5, FDXR | |
| TCA cycle | SUCLA2, SUCLG2 | |
| Transmembrane transport | ABCB7, MTCH1, SLC25A45, SLC25A10, SLC25A13, SLC25A1 | |
| Unknown function | MTFR1L, ADCK1, LRRC59, UPF0640, RMDN2, C14orf159, SND1, ISOC2, MMAA, C21orf33, BPHL, HINT2 | |
Proteins regulated by NFE2L2 or identified as interaction partners of NFE2L2
| Uniprot ID | Protein name | FC | Pathway/Function (Annotation/Reference) | Match of predicted versus observed regulation (Y/N) |
|---|---|---|---|---|
| B1ATI0 | ALDH3A2 | 2.1 | Target of NFE2L2 regulon (Kwak et al., | Y |
| A2AMV3 | AKR7A5 | 1.4 | NFE2L2‐mediated oxidative stress response (IPA), repair of lipidperoxides (Li et al., | Y |
| Q5EBQ7 | MSRA | 1.4 | Co‐cited transcription factor NFE2L2 (GePS), repair of oxidized cysteine residues (Styskal et al., | Y |
| A2A8C9 | HSP40 (DNAJC11) | 1.4 | NFE2L2‐mediated oxidative stress response (IPA) | Y |
| Q3TXQ6 | CAT | 0.7 | NFE2L2‐mediated oxidative stress response (IPA, GePS) | N |
| P08228 | SOD1 | 0.6 | NFE2L2‐mediated oxidative stress response (IPA, GePS) | N |
| Q91VS7 | MGST1 | 1.3 | NFE2L2‐mediated oxidative stress response (IPA, GePS), repair of lipidperoxides (Kelner et al., | Y |
| Q64435 | UGT1A6 | 2.6 | Co‐cited transcription factor NFE2L2 (GePS) | Y |
| O35728 | CYP4A14 | 0.4 | Co‐cited transcription factor NFE2L2 (GePS),microsomal FAO (Gambino et al., | N |
| Q8VCW9 | CYP2A12 | 1.8 | Target of the NFE2L2 regulon | Y |
| B6VGH4 | CYP1A2 | 1.6 | Target of the NFE2L2 regulon | Y |
| O35490 | BHMT | 1.9 | Target of the NFE2L2 regulon | Y |
| Q543J0 | UOX | 0.7 | Target of the NFE2L2 regulon | Y |
| O88833 | CYP4A10 | 0.5 |
Target of the NFE2L2 regulon | N |
| Q8BJL4 | LMAN2 | 1.6 | Target of the NFE2L2 regulon | Y |
| Q9D8V0‐3 | HM13 | 1.7 | Target of the NFE2L2 regulon | Y |
| O88668 | CREG1 | 0.5 | Target of the NFE2L2 regulon | N |
| Q3TJI8 | HSD11B1 | 2.0 | Co‐cited transcription factor NFE2L2 (GePS), inactivates NFE2L2 (Kratschmar et al., | – |
| A1A4A7 | PGAM5 | 0.5 | Co‐cited transcription factor NFE2L2 (GePS), tethers NFE2L2 to mitochondria (Xue et al., | – |
Kwak et al. (2003), FC – fold change reflects the mean abundance of high fat‐fed mice divided by the mean abundance of control‐fed mice.
Figure 4(A) Western blot analysis of isolated mitochondria. Samples of individual mice were pooled per diet and age group. Cohort 2 represents protein pools, which were also subjected to proteome analysis. Cohort 1 is composed of independent experimental groups for the respective ages and diets. Protein abundance was validated for nuclear factor erythroid‐derived 2 like 2 (NFE2L2), Citrate Synthase (CS), phosphoglycerate mutase 5 (PGAM5), and superoxide dismutase 2 (SOD2). (B) Band intensities were quantified and expressed relative to the mean of controls. Data are represented as means ± SD. Statistics were performed using paired, two‐tailed Student's t‐test for control (C) and high fat (HF) group of the respective ages per cohort. *P < 0.05, n = 6. M, protein ladder.